Brief group Acceptance and Commitment Therapy (ACT-i) for adults with chronic insomnia
Official title: Brief Group Acceptance and Commitment Therapy for Insomnia: Study Protocol for a Randomized Controlled Trial
Run by Babes-Bolyai University · NCT07048600 · Data updated 2026-11-12
This project will test whether a short, group Acceptance and Commitment Therapy program (ACT-i) helps adults aged 18–59 with chronic insomnia compared with an attentional control program.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 59 Years |
| Sex | All |
| Enrollment | 76 (estimated) |
| Sponsor | Babes-Bolyai University Academic / other |
| Locations | 1 site (Cluj-Napoca) |
| Status | Recruiting |
| Started | May 23, 2025 |
| Main results expected | October 15, 2026 |
| Study ends | October 30, 2026 |
| Registry record updated | September 25, 2026 |
| Trial ID | NCT07048600 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18–59 with chronic insomnia who can understand Romanian, attend online group sessions, and do not have moderate-to-severe psychiatric, neurodegenerative, or other primary sleep disorders.
✕Probably not a fit
Patients with moderate or severe psychiatric disorders, neurodegenerative disease, other primary sleep disorders (like sleep apnea), significant cognitive impairment, inability to use online sessions, or who do not understand Romanian are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, controlled, group-based intervention comparing a brief ACT-i program to an attentional control in adults with chronic insomnia. Participants aged 18–59 will attend two weekly group sessions and complete measures before treatment, two weeks after treatment, and at a three-month follow-up. Outcomes include insomnia severity plus cognitive function, depression, anxiety, psychological flexibility, and sleep-related beliefs. Sessions require Romanian language comprehension and the ability to join online with a camera and microphone, and the trial is coordinated at Babeș-Bolyai University in Cluj-Napoca.
Why it matters
Potential benefit: If successful, a brief group ACT-i could offer a shorter, more accessible behavioral option to reduce insomnia symptoms and related mood or cognitive problems.
How similar studies have gone: Cognitive-behavioral therapy for insomnia (CBT-i) has strong evidence, and early ACT-i studies are promising but ACT-i as a standalone brief group treatment remains relatively limited and needs more randomized trials.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * clinical/ subclinical diagnosis of chronic insomnia either already diagnosed by a professional, or identified with SCISD-R by our team of clinicians * age over 18 and older, but not over 59 years old; * minimal/ mild symptomatology of depression (scores ≤ 9 on PHQ-9) and/ or anxiety (scores ≤ 9 on GAD-7) or as diagnosed with SCID-5-CV; Exclusion Criteria: * diagnosed with a neurological degenerative disorder, or any moderate/ severe psychiatric disorder; * diagnosed with other sleep disorder (e.g., sleep apnea, restless legs/ periodic limb movements, circadian-based sleep disorder); * diagnosed with cognitive impairments; * unable to understand Romanian; * unable to attend to online-sessions (e.g., no laptop, microphone, camera);
Where it's running
-
Babes Bolyai University
Cluj-Napoca, Romania Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
A smart look at common sleep meds for insomnia
This trial tests how well and how safely widely used sleep medicines and OTCs work for adults with insomnia and which might be best overall.
-
Transcranial alternating current stimulation for generalized anxiety disorder and chronic insomnia
This study will try 20 sessions of transcranial alternating current stimulation (tACS) with the Nexalin device to see if it improves anxiety and sleep in adults with generalized anxiety disorder and chronic insomnia.
-
Adding yoga to usual care for adults with chronic insomnia
This trial will test whether doing a structured yoga program alongside usual care helps adults (18–65) with chronic insomnia sleep better than usual care alone.
-
SWELL cognitive behavioral therapy program for chronic insomnia in older Veterans
This project will try two ways of rolling out SWELL, a five-session CBT for chronic insomnia, to help older Veterans get and benefit from treatment.
-
Restoring everyday health and wellbeing by improving sleep
This study will try Cognitive Behavioral Therapy for Insomnia (CBT-I) in adults with chronic insomnia to see if better sleep changes stress-hormone (cortisol) patterns and improves daytime health, especially for people who sleep less than six hours a night.
-
Frontal vibration to improve sleep and memory in chronic insomnia
This study will test whether gentle low‑intensity vibrations applied to the forehead help adults with chronic insomnia sleep better and improve memory.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.